BI 655064
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for BI 655064, covering 2013-11-01 to 2024-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy [Phase 1]